Cesarean Delivery Withdrawn Phase 4 Trials for Cefazolin (DB01327)

IndicationStatusPhase
DBCOND0036001 (Cesarean Delivery)Withdrawn4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01880112Serum and Tissue Cefazolin Concentrations in Normal Weight Patients Undergoing Cesarean Delivery.Basic Science